858 Therapeutics Competitors and Similar CompaniesClear all
858 Therapeutics's competitors and similar companies include Acellera.
 858 Therapeutics 858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule medications that operate on oncology therapeutic targets, such as proteins that govern RNA and the innate immune response. | ||
Founding Date | Founding Date 2019 | Founding Date 2006 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations San Diego, US HQ | Locations Stanmore, GB HQ Barcelona, ES |
Employees | Employees 11 | Employees 14 |
Funding | ||
Latest funding round | Latest funding round $ 60m (over 4 years ago) | Latest funding round $ 54.9k (about 11 years ago) |
Total funding raised | Total funding raised $ 80.1m | Total funding raised $ 54.9k |
For sources of this data, please see the company profile